Publications

2022

Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999-2014.

Cancer.128(15):2978-2987[DOI] 10.1002/cncr.34258.[PMID] 35608563.

PubMed·Publisher's Site

2022

Impact of Medicaid Expansion on Pancreatic Cancer: An Examination of Sociodemographic Disparity in 1-Year Survival.

Journal of the American College of Surgeons.234(1):75-84[DOI] 10.1097/XCS.0000000000000018.[PMID] 35213464.

1 citations·PubMed·Publisher's Site

2022

Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning.

Cancer research.82(15):2792-2806[DOI] 10.1158/0008-5472.CAN-21-2318.[PMID] 35654752.

1 citations·PubMed·Publisher's Site

2022

Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma.

Urologic oncology.40(4):168.e11-168.e19[DOI] 10.1016/j.urolonc.2021.12.005.[PMID] 35148948.

2 citations·PubMed·Publisher's Site

2021

Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.

Urologic oncology.39(2):135.e1-135.e8[DOI] 10.1016/j.urolonc.2020.08.028.[PMID] 33309297.

1 citations·PubMed·Publisher's Site

2021

Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer.

Clinical epigenetics.13(1):12-[DOI] 10.1186/s13148-020-00998-z.[PMID] 33461589.

6 citations·PubMed·Publisher's Site

2021

Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of Florida.

Cancer causes & control : CCC.32(11):1269-1278[DOI] 10.1007/s10552-021-01477-3.[PMID] 34259972.

PubMed·Publisher's Site

2020

Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.

Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.40(2):86-90[DOI] 10.1097/PSN.0000000000000306.[PMID] 32459756.

4 citations·PubMed·Publisher's Site

2020

Breast cancer in women: a descriptive analysis of the national cancer database.

Acta bio-medica : Atenei Parmensis.91(2):332-341[DOI] 10.23750/abm.v91i2.8399.[PMID] 32420970.

16 citations·PubMed·Publisher's Site

2020

Chronic Tenosynovitis of the Upper Extremities Caused by Mycobacterium kansasii : A Clinical Case and Systematic Review of Literature.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.53(1):25-35[DOI] 10.1055/s-0040-1709377.[PMID] 32367915.

PubMed·Publisher's Site

2020

Influence of gene expression on survival of clear cell renal cell carcinoma.

Cancer medicine.9(22):8662-8675[DOI] 10.1002/cam4.3475.[PMID] 32986937.

10 citations·PubMed·Publisher's Site

2020

National Analysis of Patients With Ulcerated Melanoma in the United States.

Anticancer research.40(2):1055-1058[DOI] 10.21873/anticanres.14042.[PMID] 32014953.

3 citations·PubMed·Publisher's Site

2019

Delay to Colectomy and Survival for Patients Diagnosed with Colon Cancer.

Journal of investigative surgery : the official journal of the Academy of Surgical Research.32(4):350-357[DOI] 10.1080/08941939.2017.1421732.[PMID] 29351008.

19 citations·PubMed·Publisher's Site

2019

Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis.

Anticancer research.39(12):6877-6880[DOI] 10.21873/anticanres.13906.[PMID] 31810956.

2 citations·PubMed·Publisher's Site

2019

Influence of Facility Characteristics on Access to Breast Reconstruction: A 12-Year National Cancer Database Analysis.

Anticancer research.39(12):6881-6885[DOI] 10.21873/anticanres.13907.[PMID] 31810957.

3 citations·PubMed·Publisher's Site

2019

Osteosarcoma of the Upper Extremities: A National Analysis of the US Population.

Anticancer research.39(10):5663-5668[DOI] 10.21873/anticanres.13763.[PMID] 31570464.

4 citations·PubMed·Publisher's Site

2019

Survival Disparities in Male Patients With Breast Cancer.

Anticancer research.39(10):5669-5674[DOI] 10.21873/anticanres.13764.[PMID] 31570465.

5 citations·PubMed·Publisher's Site

2019

Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.

Translational cancer research.8(Suppl 4):S397-S403[DOI] 10.21037/tcr.2019.06.36.[PMID] 35117117.

PubMed·Publisher's Site

2019

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

PLoS medicine.16(1):e1002724-[DOI] 10.1371/journal.pmed.1002724.[PMID] 30605491.

44 citations·PubMed·Publisher's Site

2019

What Factors Define Limb Salvage or Amputation Surgery in Osteosarcoma of the Upper Extremities?

Anticancer research.39(12):6807-6811[DOI] 10.21873/anticanres.13896.[PMID] 31810946.

2 citations·PubMed·Publisher's Site

2019

Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?

Anticancer research.39(9):5027-5031[DOI] 10.21873/anticanres.13693.[PMID] 31519610.

3 citations·PubMed·Publisher's Site

2018

Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.

International journal of cancer.142(4):747-756[DOI] 10.1002/ijc.31103.[PMID] 29023769.

7 citations·PubMed·Publisher's Site

2018

Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.

Journal of clinical and experimental hepatology.8(4):375-379[DOI] 10.1016/j.jceh.2018.01.004.[PMID] 30563998.

2 citations·PubMed·Publisher's Site

2018

The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study.

The American journal of hospice & palliative care.35(10):1295-1303[DOI] 10.1177/1049909118765092.[PMID] 29580075.

19 citations·PubMed·Publisher's Site

2017

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.

BMC urology.17(1):19-[DOI] 10.1186/s12894-017-0209-3.[PMID] 28327121.

17 citations·PubMed·Publisher's Site

2017

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.

European urology.71(6):979-985[DOI] 10.1016/j.eururo.2016.11.018.[PMID] 27899233.

44 citations·PubMed·Publisher's Site

2017

Coffee consumption and risk of renal cell carcinoma.

Cancer causes & control : CCC.28(8):857-866[DOI] 10.1007/s10552-017-0913-z.[PMID] 28647866.

9 citations·PubMed·Publisher's Site

2017

Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.

Rare tumors.9(2):6834-[DOI] 10.4081/rt.2017.6834.[PMID] 28975018.

6 citations·PubMed·Publisher's Site

2017

GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.

The British journal of radiology.90(1075):20170174-[DOI] 10.1259/bjr.20170174.[PMID] 28486040.

7 citations·PubMed·Publisher's Site

2017

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Nature communications.8():15724-[DOI] 10.1038/ncomms15724.[PMID] 28598434.

59 citations·PubMed·Publisher's Site

2017

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.35(32):3706-3713[DOI] 10.1200/JCO.2017.73.3238.[PMID] 28976794.

26 citations·PubMed·Publisher's Site

2017

Timing interval from peri-prostatic block to biopsy impacts procedural pain.

The Canadian journal of urology.24(3):8795-8801[DOI] .[PMID] 28646934.

1 citations·PubMed·Publisher's Site

2016

An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.

PloS one.11(3):e0151785-[DOI] 10.1371/journal.pone.0151785.[PMID] 26986977.

1 citations·PubMed·Publisher's Site

2016

Author Reply.

Urology.89():61-2[DOI] 10.1016/j.urology.2015.10.039.[PMID] 26797576.

PubMed·Publisher's Site

2016

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.

The Journal of urology.195(1):180-7[DOI] 10.1016/j.juro.2015.07.113.[PMID] 26300218.

93 citations·PubMed·Publisher's Site

2016

Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.

Clinical imaging.40(5):902-6[DOI] 10.1016/j.clinimag.2016.04.008.[PMID] 27183138.

4 citations·PubMed·Publisher's Site

2016

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.29(1):34-42[DOI] 10.1038/modpathol.2015.123.[PMID] 26516698.

42 citations·PubMed·Publisher's Site

2016

Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.

Urology.89():54-60[DOI] 10.1016/j.urology.2015.10.034.[PMID] 26723183.

24 citations·PubMed·Publisher's Site

2016

Radical Prostatectomy Trends in the United States: 1998 to 2011.

Mayo Clinic proceedings.91(1):10-6[DOI] 10.1016/j.mayocp.2015.09.018.[PMID] 26763510.

25 citations·PubMed·Publisher's Site

2016

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

European urology focus.2(6):608-615[DOI] 10.1016/j.euf.2016.03.008.[PMID] 28723492.

5 citations·PubMed·Publisher's Site

2015

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.

PloS one.10(7):e0132831-[DOI] 10.1371/journal.pone.0132831.[PMID] 26181416.

7 citations·PubMed·Publisher's Site

2015

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

Urologic oncology.33(2):68.e17-23[DOI] 10.1016/j.urolonc.2014.07.019.[PMID] 25175426.

9 citations·PubMed·Publisher's Site

2015

Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.

Psycho-oncology.24(4):451-7[DOI] 10.1002/pon.3605.[PMID] 24953309.

9 citations·PubMed·Publisher's Site

2015

Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.

Journal of surgical oncology.111(4):483-4[DOI] 10.1002/jso.23841.[PMID] 25492622.

2 citations·PubMed·Publisher's Site

2015

Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.

BMC urology.15():58-[DOI] 10.1186/s12894-015-0057-y.[PMID] 26126615.

4 citations·PubMed·Publisher's Site

2015

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.

Urologic oncology.33(1):23.e9-23.e14[DOI] 10.1016/j.urolonc.2014.10.014.[PMID] 25465300.

33 citations·PubMed·Publisher's Site

2015

Prospective evaluation of the association of adherent perinephric fat with perioperative outcomes of robotic-assisted partial nephrectomy.

Urology.85(4):836-42[DOI] 10.1016/j.urology.2014.12.017.[PMID] 25669734.

24 citations·PubMed·Publisher's Site

2015

Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.

Rare tumors.7(1):5719-[DOI] 10.4081/rt.2015.5719.[PMID] 25918615.

3 citations·PubMed·Publisher's Site

2015

Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Mayo Clinic proceedings.90(3):366-71[DOI] 10.1016/j.mayocp.2015.01.001.[PMID] 25659636.

11 citations·PubMed·Publisher's Site

2015

Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.36(10):7431-7[DOI] 10.1007/s13277-015-3459-2.[PMID] 25900876.

13 citations·PubMed·Publisher's Site

2014

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.

BMC urology.14():14-[DOI] 10.1186/1471-2490-14-14.[PMID] 24479813.

33 citations·PubMed·Publisher's Site

2014

Correlation of radiographic renal cell carcinoma tumor volume utilizing computed tomography and magnetic resonance imaging compared with pathological tumor volume.

Scandinavian journal of urology.48(5):453-9[DOI] 10.3109/21681805.2013.876551.[PMID] 24990768.

4 citations·PubMed·Publisher's Site

2014

Evaluation of awareness of risk factors for kidney cancer among patients presenting to a urology clinic.

Scandinavian journal of urology.48(3):239-44[DOI] 10.3109/21681805.2013.863803.[PMID] 24328689.

6 citations·PubMed·Publisher's Site

2014

External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.23(9):1804-12[DOI] 10.1158/1055-9965.EPI-14-0029.[PMID] 24920641.

36 citations·PubMed·Publisher's Site

2014

Genomic medicine and incidental findings: balancing actionability and patient autonomy.

Mayo Clinic proceedings.89(6):718-21[DOI] 10.1016/j.mayocp.2014.04.008.[PMID] 24943691.

10 citations·PubMed·Publisher's Site

2014

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

European urology.66(5):929-35[DOI] 10.1016/j.eururo.2013.12.017.[PMID] 24388441.

27 citations·PubMed·Publisher's Site

2014

Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.

PloS one.9(6):e96705-[DOI] 10.1371/journal.pone.0096705.[PMID] 24896845.

67 citations·PubMed·Publisher's Site

2014

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.

Cancer.120(7):1059-67[DOI] 10.1002/cncr.28521.[PMID] 24382589.

110 citations·PubMed·Publisher's Site

2014

MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.

Proteomics.14(7-8):924-35[DOI] 10.1002/pmic.201300434.[PMID] 24497498.

57 citations·PubMed·Publisher's Site

2014

Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy.

European urology.66(6):1165-71[DOI] 10.1016/j.eururo.2014.08.054.[PMID] 25192968.

136 citations·PubMed·Publisher's Site

2014

Prospective evaluation of 24-hour urine profiles following bariatric surgery in a modern comprehensive care bariatric clinic.

Clinical nephrology.81(5):331-7[DOI] 10.5414/CN108154.[PMID] 24495903.

2 citations·PubMed·Publisher's Site

2014

Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.

European urology.66(5):e90-1[DOI] 10.1016/j.eururo.2014.05.009.[PMID] 24877662.

1 citations·PubMed·Publisher's Site

2014

Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.

Carcinogenesis.35(4):822-7[DOI] 10.1093/carcin/bgt485.[PMID] 24374825.

17 citations·PubMed·Publisher's Site

2013

Age-period-cohort analysis of renal cell carcinoma in United States adults.

Urology.82(1):43-7[DOI] 10.1016/j.urology.2013.02.065.[PMID] 23706585.

23 citations·PubMed·Publisher's Site

2013

Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.

BMC urology.13():52-[DOI] 10.1186/1471-2490-13-52.[PMID] 24148752.

4 citations·PubMed·Publisher's Site

2013

Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.

Current urology reports.14(1):26-31[DOI] 10.1007/s11934-012-0292-7.[PMID] 23184624.

26 citations·PubMed·Publisher's Site

2013

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer.

ISRN oncology.2013():239241-[DOI] 10.1155/2013/239241.[PMID] 23606986.

2 citations·PubMed·Publisher's Site

2013

Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.

Psycho-oncology.22(6):1328-35[DOI] 10.1002/pon.3138.[PMID] 22855322.

35 citations·PubMed·Publisher's Site

2013

Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.

Cancer immunology research.1(6):378-85[DOI] 10.1158/2326-6066.CIR-13-0042.[PMID] 24778130.

29 citations·PubMed·Publisher's Site

2013

Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.

Journal of radiation oncology.2(3):309-314[DOI] .[PMID] 24073305.

PubMed·Publisher's Site

2013

Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.

Scandinavian journal of urology.47(6):472-5[DOI] 10.3109/21681805.2013.814071.[PMID] 23883351.

10 citations·PubMed·Publisher's Site

2013

Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery.

Journal of the American College of Surgeons.216(3):380-9; quiz 511[DOI] 10.1016/j.jamcollsurg.2012.11.004.[PMID] 23266421.

75 citations·PubMed·Publisher's Site

2012

Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.

Journal of immunotherapy (Hagerstown, Md. : 1997).35(9):711-5[DOI] 10.1097/CJI.0b013e3182742c27.[PMID] 23090080.

17 citations·PubMed·Publisher's Site

2012

Determination of ureter stent appearance on dual-energy computed tomography scan.

Urology.80(5):986-9[DOI] 10.1016/j.urology.2012.07.005.[PMID] 22921702.

8 citations·PubMed·Publisher's Site

2012

Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?

International urology and nephrology.44(4):1005-12[DOI] 10.1007/s11255-012-0168-2.[PMID] 22528581.

6 citations·PubMed·Publisher's Site

2012

Dorsal vaginal graft urethroplasty for female urethral stricture disease.

BJU international.110(11 Pt C):E1090-5[DOI] 10.1111/j.1464-410X.2012.11233.x.[PMID] 22594612.

37 citations·PubMed·Publisher's Site

2012

Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.

The Prostate.72(16):1757-66[DOI] 10.1002/pros.22528.[PMID] 22513981.

9 citations·PubMed·Publisher's Site

2012

Expression of endothelin 2 and localized clear cell renal cell carcinoma.

Human pathology.43(6):843-9[DOI] 10.1016/j.humpath.2011.07.011.[PMID] 22047647.

10 citations·PubMed·Publisher's Site

2012

Impact of fellowship training on one-year outcomes of robotic-assisted prostatectomy.

JSLS : Journal of the Society of Laparoendoscopic Surgeons.16(2):195-201[DOI] .[PMID] 23477165.

6 citations·PubMed·Publisher's Site

2012

Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.

Urology.80(1):147-50[DOI] 10.1016/j.urology.2012.04.013.[PMID] 22748870.

5 citations·PubMed·Publisher's Site

2012

The effect of robot-assisted laparoscopic prostatectomy on nocturia.

Journal of endourology.26(7):861-5[DOI] 10.1089/end.2011.0611.[PMID] 22332794.

5 citations·PubMed·Publisher's Site

2012

Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.

BJU international.110(7):956-60[DOI] 10.1111/j.1464-410X.2012.10937.x.[PMID] 22300498.

25 citations·PubMed·Publisher's Site

2012

Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?

Annals of surgical oncology.19(4):1129-36[DOI] 10.1245/s10434-011-2080-x.[PMID] 21975859.

24 citations·PubMed·Publisher's Site

2011

Estimation of prostate size in community-dwelling men.

Urology.77(2):422-6[DOI] 10.1016/j.urology.2010.05.044.[PMID] 20800880.

3 citations·PubMed·Publisher's Site

2011

Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.

International journal of radiation oncology, biology, physics.79(5):1343-9[DOI] 10.1016/j.ijrobp.2010.01.061.[PMID] 20598810.

32 citations·PubMed·Publisher's Site

2011

Evaluation of pancreatic damage after extracorporeal shock wave lithotripsy, percutaneous stone surgery, and ureteroscopy.

Urology.77(6):1288-91[DOI] 10.1016/j.urology.2010.08.066.[PMID] 21215433.

2 citations·PubMed·Publisher's Site

2009

Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.18(2):444-53[DOI] 10.1158/1055-9965.EPI-08-1002.[PMID] 19190164.

58 citations·PubMed·Publisher's Site

2009

Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.

Mayo Clinic proceedings.84(8):702-6[DOI] 10.1016/S0025-6196(11)60520-X.[PMID] 19648387.

18 citations·PubMed·Publisher's Site

2009

Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Cancer.115(10):2092-103[DOI] 10.1002/cncr.24263.[PMID] 19296514.

86 citations·PubMed·Publisher's Site

2009

Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.

International journal of radiation oncology, biology, physics.75(5):1364-70[DOI] 10.1016/j.ijrobp.2008.12.061.[PMID] 19464826.

17 citations·PubMed·Publisher's Site

2008

A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.

The Journal of biological chemistry.283(26):18344-54[DOI] 10.1074/jbc.M801192200.[PMID] 18407999.

123 citations·PubMed·Publisher's Site

2008

Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.

Human pathology.39(8):1176-84[DOI] 10.1016/j.humpath.2007.12.009.[PMID] 18538369.

13 citations·PubMed·Publisher's Site

2008

Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.

International journal of urology : official journal of the Japanese Urological Association.15(4):304-8[DOI] 10.1111/j.1442-2042.2008.01994.x.[PMID] 18380816.

18 citations·PubMed·Publisher's Site

2008

Evaluation of the impact of body mass index on outcome among renal mass patients treated with hand-assisted laparoscopic radical nephrectomy.

Journal of endourology.22(2):301-6[DOI] 10.1089/end.2007.0250.[PMID] 18294037.

9 citations·PubMed·Publisher's Site

2008

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.

Cancer.112(7):1471-9[DOI] 10.1002/cncr.23296.[PMID] 18260086.

95 citations·PubMed·Publisher's Site

2008

Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies.

Journal of the National Cancer Institute.100(23):1695-706[DOI] 10.1093/jnci/djn386.[PMID] 19033572.

45 citations·PubMed·Publisher's Site

2007

Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies.

Journal of the National Cancer Institute.99(10):801-10[DOI] .[PMID] 17505075.

74 citations·PubMed·Publisher's Site

2007

Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies.

International journal of cancer.121(10):2246-53[DOI] .[PMID] 17583573.

41 citations·PubMed·Publisher's Site

2007

Re: The epidemiology of renal cell carcinoma.

The Journal of urology.177(5):1953; author reply 1953-4[DOI] .[PMID] 17437854.

PubMed·Publisher's Site

2007

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research.13(16):4740-9[DOI] .[PMID] 17699851.

237 citations·PubMed·Publisher's Site

2007

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research.13(6):1749-56[DOI] .[PMID] 17363528.

80 citations·PubMed·Publisher's Site

2006

Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.

Urology.68(4):741-6[DOI] .[PMID] 17070345.

97 citations·PubMed·Publisher's Site

2006

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

Cancer.107(1):37-45[DOI] .[PMID] 16736510.

72 citations·PubMed·Publisher's Site

2006

Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.

The Journal of urology.176(3):985-90[DOI] .[PMID] 16890677.

92 citations·PubMed·Publisher's Site

2006

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Cancer research.66(7):3381-5[DOI] .[PMID] 16585157.

679 citations·PubMed·Publisher's Site

2005

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

Clinical cancer research : an official journal of the American Association for Cancer Research.11(14):5128-39[DOI] .[PMID] 16033827.

116 citations·PubMed·Publisher's Site

2005

Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.

Urology.65(6):1090-5[DOI] .[PMID] 15893810.

22 citations·PubMed·Publisher's Site

2004

History of urinary tract infection and risk of renal cell carcinoma.

American journal of epidemiology.159(1):42-8[DOI] .[PMID] 14693658.

37 citations·PubMed·Publisher's Site

2004

Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.

Cancer.100(12):2577-82[DOI] .[PMID] 15197799.

20 citations·PubMed·Publisher's Site

2003

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.

The Journal of urology.170(2 Pt 1):420-4[DOI] .[PMID] 12853790.

44 citations·PubMed·Publisher's Site

2003

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Cancer.97(7):1663-71[DOI] .[PMID] 12655523.

510 citations·PubMed·Publisher's Site

2003

Smoking cessation and renal cell carcinoma.

Annals of epidemiology.13(4):245-51[DOI] .[PMID] 12684190.

38 citations·PubMed·Publisher's Site

2002

Gender, alcohol consumption, and renal cell carcinoma.

American journal of epidemiology.155(5):455-62[DOI] .[PMID] 11867357.

43 citations·PubMed·Publisher's Site

2002

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.

Human pathology.33(8):801-5[DOI] .[PMID] 12203212.

49 citations·PubMed·Publisher's Site

Show More